Expertise in
5
conditions

Dr. Maura M. Barry

Hematology
University Of Vermont Medical Center
111 Colchester Ave, 
Burlington, VT 
Accepting New Patients
Offers Telehealth
Expertise in
5
conditions
University Of Vermont Medical Center
111 Colchester Ave, 
Burlington, VT 

Overview

Maura Barry is a Hematologist practicing medicine in Burlington, Vermont.

Dr. Barry is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Pancreatectomy.

She is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 5 clinical trials. Dr. Barry is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in VT

Hospital Affiliations

Porter Hospital Inc
The University Of Vermont Health Network-Alice Hy
Northwestern Medical Center Inc
Univ. Of Vermont - Fletcher Allen Health Care
The University Of Vermont Health Network - Champl

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

University of Vermont Medical Center
111 Colchester Ave, Burlington, VT 05401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
A Phase I/II Study of Indoximod in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Adenocarcinoma of the Pancreas
A Phase I/II Study of Indoximod in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Adenocarcinoma of the Pancreas
Enrollment Status: Completed
Publish Date: April 03, 2026
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Randomized Phase II Study of Perioperative mFOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
A Randomized Phase II Study of Perioperative mFOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 19, 2022
Intervention Type: Drug, Procedure
Study Drugs: Fluorouracil, Gemcitabine hydrochloride, Irinotecan hydrochloride, Oxaliplatin, Paclitaxel albumin-stabilized nanoparticle formulation
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

10 Total Publications

Understanding caregivers' experiences and perspectives on online support: a qualitative study.
Understanding caregivers' experiences and perspectives on online support: a qualitative study.
Journal: Aging & mental health
Published: May 08, 2026
Similar Doctors
Expertise in
6
conditions
Dr. Mary Cushman
Hematology
Expertise in
6
conditions
Dr. Mary Cushman
Hematology
Referral may be required

University Of Vermont Medical Center

111 Colchester Ave, 
Burlington, VT 
 (0.1 miles away)
802-847-8400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mary Cushman is a Hematologist practicing medicine in Burlington, Vermont. Dr. Cushman is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Deep Vein Thrombosis, Embolectomy, and Hormone Replacement Therapy (HRT). Dr. Cushman is currently accepting new patients.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

University Of Vermont Medical Center

111 Colchester Ave, 
Burlington, VT 
 (0.1 miles away)
802-847-8400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Neil Zakai is a Hematologist practicing medicine in Burlington, Vermont. Dr. Zakai is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Antiphospholipid Syndrome, Deep Vein Thrombosis, and Bone Marrow Aspiration. Dr. Zakai is currently accepting new patients.

Expertise in
46
conditions
Expertise in
46
conditions
Referral may be required

University Of Vermont Medical Center

111 Colchester Ave, 
Burlington, VT 
 (0.1 miles away)
802-847-8400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Julian Sprague is a Hematologist practicing medicine in Burlington, Vermont. Dr. Sprague is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Autoimmune Hemolytic Anemia, Large-Cell Immunoblastic Lymphoma, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sprague is currently accepting new patients.

Frequently Asked Questions about Dr. Maura M. Barry

How do I make an appointment with Dr. Maura M. Barry?

You can book an appointment with Dr. Maura M. Barry by calling their office at 802-847-8400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Maura M. Barry a top-rated expert for Large-Cell Immunoblastic Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Maura M. Barry is classified as an Advanced expert for Large-Cell Immunoblastic Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Maura M. Barry specialize in?

While Dr. Maura M. Barry is a Hematology, they have specific expertise in Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Maura M. Barry participate in research or clinical trials?

Yes. Dr. Maura M. Barry has published 10 articles and abstracts on conditions like Large-Cell Immunoblastic Lymphoma. You can view a list of Dr. Maura M. Barry's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Maura M. Barry accept my insurance?

Dr. Maura M. Barry accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 802-847-8400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Barry's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile